EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Systematic Review of Methods for Measuring Circulating Cell-Free DNA in Plasma of Healthy Individuals

Aaron Das, Ilirjana Gocaj, Alisa Yurovsky iD

Diagnostics · 10.03.2026 · 16 (6) · 821

DOI: 10.3390/diagnostics16060821 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 10.03.2026. Verfasst von Aaron Das und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY 11794, USA. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stony Brook University, Stony Brook University IDEA Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Standardizing measurement of circulating cell-free DNA (cfDNA) in healthy individuals is critical for its application as a reference in biomarker research, yet methodological variability remains poorly documented.

Methods

We systematically reviewed 35 studies (n = 1250 healthy subjects) assessing how pre-analytical handling, extraction kits, and quantification methods influence plasma cfDNA levels. We identified quantification approaches (qPCR vs. fluorometry) and use of custom extraction kits as the strongest drivers of variability.

Results

In qPCR studies, including ≥ 40 subjects reduced variability, underscoring the importance of adequate sample size. Commercial kits produced more consistent yields than in-house protocols; in our dataset, many studies used Qiagen’s QIAamp Circulating Nucleic Acid Kit, which has historically served as a widely used reference platform. Blood collection in EDTA tubes had minimal impact when commercial kits were used.

Conclusions

Based on these findings, we recommend EDTA tubes, a standardized commercial extraction kit, and qPCR quantification to minimize cfDNA measurement variability in healthy cohorts. Finally, we provide expected cfDNA ranges for healthy individuals based on methodological flow, which can guide future benchmarking efforts and biomarker studies, improving comparability and early-detection research.

Schlagwörter

Stichwörter der Autor:innen

biomarkercell-free DNA (cfDNA)disease detectionearly detectionhealthy controls

Autor:innen und Institutionen

  • Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY 11794, USA.

ORCID-Profile: Alisa Yurovsky

Förderung

  • Stony Brook University
  • Stony Brook University IDEA Fellowship

Zitieren

APA

Das, A., Gocaj, I., & Yurovsky, A. (2026). Systematic Review of Methods for Measuring Circulating Cell-Free DNA in Plasma of Healthy Individuals. Diagnostics, 16(6), 821. https://doi.org/10.3390/diagnostics16060821

Vancouver

Das A, Gocaj I, Yurovsky A. Systematic Review of Methods for Measuring Circulating Cell-Free DNA in Plasma of Healthy Individuals. Diagnostics. 2026;16(6):821. doi:10.3390/diagnostics16060821

BibTeX
@article{Das2026,
  author = {Das, Aaron and Gocaj, Ilirjana and Yurovsky, Alisa},
  title = {Systematic Review of Methods for Measuring Circulating Cell-Free DNA in Plasma of Healthy Individuals},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {6},
  pages = {821},
  doi = {10.3390/diagnostics16060821}
}
Kostenlos starten →